ACHE and Alzheimer disease: The Acetyl Cholinesterase (AChE) inhibitors are being major and large amount developed class of drugs approved for AD therapy have been approved by Food and Administration (FDA) and European Medicines Evaluation Agency (EMEA) example such as donepezil, rivastigime and galanthamine for symptomatic treatment of behavioural and psychiatric symptoms of AD [1].